CTT PHARMACEUTICAL HOLDINGS, INC. purchased $112 of CTTH
CTT PHARMACEUTICAL HOLDINGS, INC. (CEO) purchased 1,800 shares of CTT PHARMACEUTICAL HOLDINGS, INC. (CTTH) at $0.06 on 2026-08-14.
CTT PHARMACEUTICAL HOLDINGS, INC.
No enriched coverage for $CTTH in the last 7 days.
CTT PHARMACEUTICAL HOLDINGS, INC. (CEO) purchased 1,800 shares of CTT PHARMACEUTICAL HOLDINGS, INC. (CTTH) at $0.06 on 2026-08-14.
CTT PHARMACEUTICAL HOLDINGS, INC. (CEO) purchased 7,700 shares of CTT PHARMACEUTICAL HOLDINGS, INC. (CTTH) at $0.06 on 2026-08-07.
In the last 30 days, CTTH insiders filed 2 SEC Form 4 transactions — 2 purchases ($612) and no sales. The most active reporter was CTT PHARMACEUTICAL HOLDINGS, INC., CEO, with 2 filings.
A small insider open-market buy signals personal confidence, but the disclosed dollar value is minor and unlikely to drive material repricing by itself.
A small insider open-market buy by the CEO, with limited expected impact on near-term fundamentals or valuation.
alphai scores every news story that mentions CTTH with an AI model for sentiment and relevance, and aggregates insider trades from CTT PHARMACEUTICAL HOLDINGS, INC.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
CTT PHARMACEUTICAL HOLDINGS, INC. (CEO) purchased 1,800 shares of CTT PHARMACEUTICAL HOLDINGS, INC. (CTTH) at $0.06 on 2026-08-14.
1 min readCTT PHARMACEUTICAL HOLDINGS, INC. (CEO) purchased 7,700 shares of CTT PHARMACEUTICAL HOLDINGS, INC. (CTTH) at $0.06 on 2026-08-07.
1 min read